Literature DB >> 300732

Response of human osteosarcoma in vitro to irradiation: evidence for unusual cellular repair activity.

R Weichselbaum, J B Little, J Nove.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 300732     DOI： 10.1080/09553007714550351

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN： 0020-7616


× No keyword cloud information.
  6 in total

Review 1.  Less well known parameters of in vitro radiosensitivity.

Authors:  S Vijayakumar; T C Ng; I Koumoundouros; P D Higgins; F J Thomas
Journal:  J Natl Med Assoc       Date:  1989-07       Impact factor: 1.798

2.  CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma.

Authors:  Qian Ran; Feng Jin; Yang Xiang; Lixin Xiang; Qiushi Wang; Fengjie Li; Li Chen; Yuan Zhang; Chun Wu; Luping Zhou; Yanni Xiao; Lili Chen; Jiang Wu; Jiang F Zhong; Shengwen Calvin Li; Zhongjun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

3.  Effects of adenosine deaminase inhibitor 2'-deoxycoformycin on the repair and expression of potentially lethal damage sensitive to beta-araA.

Authors:  G Iliakis; F Q Ngo
Journal:  Radiat Environ Biophys       Date:  1985       Impact factor: 1.925

4.  Radiotherapy in the Management of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis.

Authors:  Mateusz Jacek Spałek; Jan Poleszczuk; Anna Małgorzata Czarnecka; Monika Dudzisz-Śledź; Aleksandra Napieralska; Jacek Matysiakiewicz; Marzanna Chojnacka; Anna Raciborska; Aleksandra Sztuder; Adam Maciejczyk; Agata Szulc; Tomasz Skóra; Bożena Cybulska-Stopa; Tomasz Winiecki; Joanna Kaźmierska; Bartłomiej Tomasik; Jacek Fijuth; Piotr Rutkowski
Journal:  Cells       Date:  2021-02-10       Impact factor: 6.600

5.  Inhibition of the recovery from potentially lethal damage by lonidamine.

Authors:  G M Hahn; I van Kersen; B Silvestrini
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

6.  Cellular repair factors influencing radiocurability of human malignant tumours.

Authors:  R R Weichselbaum; A Schmit; J B Little
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.